Is Vaccine Effectiveness Really Waning, or is this Just an Excuse for More of the Same?

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite

November 25, 2021

In order for the effectiveness of something to wane, it first has to be effective. This common sense logic doesn’t pass the smell test when it comes to the outcomes of the COVID-19 mRNA vaccine clinical trials. Absolute risk reductions (ARR) of the Pfizer and Moderna vaccines were 0.708% and 1.1439%, respectively (rounded here to the nearest ten-thousandth of one percent). These ultralow numbers of the vaccines’ effectiveness to prevent COVID-19 infections were never reported to the public. Instead, the public was fed the lie that the vaccines were approximately 95% effective: Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials.

Otherwise known as “vaccine efficacy,” this 95% distorted figure is calculated by dividing the ARR by the placebo infection rate of a clinical trial, which raises the ARR to a higher number. How much higher? See for yourself. The Pfizer and Moderna placebo infection rates from the trials are 0.745% and 1.2163%, respectively.

Pfizer: 0.708% ARR / 0.745% placebo infection = 95% vaccine efficacy


Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee